FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

Volker Heinemann, Sebastian Stintzing, Alexander Kiani et al.|British Journal of Cancer|2020

Cited by 187